PASSEDHarris County Commissioners Court · 2025-11-20

Harris County is extending its vaccine purchase agreements with Merck, GlaxoSmithKline, and Sanofi Pasteur through December 31, 2025 for the Refugee Health Screening Program, using existing federal grant funds with no additional cost.

What it means for you

Refugees receiving health screenings through Harris County Public Health Services will continue to have access to vaccines purchased under this extended agreement at no new cost to the county.

Outcome

A motion was made by Commissioner Ramsey, seconded by Commissioner Garcia, that this item be approved. The motion carried by the following vote: (4-0)

How each member voted

Lina Hidalgo (County Judge): AbsentRodney Ellis (Commissioner, Precinct 1): AyeAdrian Garcia (Commissioner, Precinct 2): AyeTom S. Ramsey (Commissioner, Precinct 3): AyeLesley Briones (Commissioner, Precinct 4): Aye

4–0, per the official record.

Health — see all →Harris County

Official source

Official meeting record — Harris County Legistar ↗

The record includes an individually-attributed vote for this item, shown above.

Quick answersfrom the official record

Who's paid?Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; Sanofi Pasteur, Inc.; Refugee Health Screening Program participantsLegistar record ↗

Which fund?U.S. Department of Health and Human Services Refugee Medical Assistance Program grant funds; no additional fundsLegistar record ↗

Who decides?Decided by a vote of the Harris County Commissioners Court. Public Health Services brought it forward. Taken up at the November 20, 2025 meeting — Adopted.Legistar record ↗

The official caption doesn't name a dollar amount — full details in the official Legistar record ↗

Cite this: https://plaindocket.com/item/real-hc25-7441-174235 — data from official records via PlainDocket.